https://cabrieladvisory.com/press-release/wex-pharmaceuticals-inc-announces-abstract-and-poster-presentation-at-pain-in-europe-xiii-the-13th-congress-of-the-european-pain-federation-efic-on-the-lead-compound-ttx-halneuron/ 2023-11-29T06:42:48+00:00 https://cabrieladvisory.com/press-release/wex-pharmaceuticals-inc-announces-abstract-and-poster-presentation-on-halneuron-at-pain-in-europe-xiii-the-13th-congress-of-the-european-pain-federation-efic/ 2023-11-29T06:50:15+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-addition-of-intellectual-property-for-its-novel-development-and-use-of-tetrodotoxin-ttx-to-relieve-pain/ 2023-11-29T06:51:47+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-enrolls-in-korea-as-part-of-the-multinational-phase-2b-clinical-trial-evaluating-the-efficacy-and-safety-of-halneuron-in-the-treatment-of-chemotherapy-induce/ 2023-11-29T06:52:38+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-management-changes/ 2023-11-29T06:53:33+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-enrolls-the-first-patient-in-the-phase-2b-clinical-trial-evaluating-the-efficacy-and-safety-of-halneuron-in-the-treatment-of-chemotherapy-induced/ 2023-11-29T06:54:13+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-authorization-for-the-conduct-of-a-chemotherapy-induced-neuropathic-pain-clinical-trial-in-china-singapore-taiwan-korea-usa-and-canada/ 2023-11-29T06:55:11+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-a-scientific-poster-presentation-at-the-iasp-world-congress-on-pain-on-its-lead-compound-halneuron/ 2023-11-29T06:55:43+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-abstract-and-poster-presentation-at-the-iasp-world-congress-on-pain-on-the-lead-compound-ttx-halneuron/ 2023-11-29T06:56:25+00:00 https://cabrieladvisory.com/press-release/news-brief-publication-of-two-papers-using-halneuron/ 2023-11-29T06:56:55+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-successfully-completes-cardiac-safety-clinic-trial-of-halneuron/ 2023-11-29T06:57:25+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-enrolls-in-korea-as-part-of-the-multinational-phase-2b-clinical-trial-evaluating-the-efficacy-and-safety-of-halneuron-in-the-treatment-of-chemotherapy-induce/ 2023-11-29T07:00:27+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-management-changes/ 2023-11-29T07:01:00+00:00 https://cabrieladvisory.com/press-release/%e6%96%b0%e8%81%9e%e7%a8%bf-%e9%95%b7%e6%b1%9f%e7%94%9f%e5%91%bd%e7%a7%91%e6%8a%80%e9%8e%ae%e7%97%9b%e8%97%a5%e7%89%a9%e7%a0%94%e7%99%bc%e6%96%b0%e9%87%8c%e7%a8%8b%e7%8d%b2%e7%be%8e%e5%8a%a0/ 2023-11-29T07:02:20+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-enrolls-the-first-patient-in-the-phase-2b-clinical-trial-evaluating-the-efficacy-and-safety-of-halneuron-in-the-treatment-of-chemotherapy-induced/ 2023-11-29T07:02:51+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-authorization-for-the-conduct-of-a-chemotherapy-induced-neuropathic-pain-clinical-trial-in-china-singapore-taiwan-korea-usa-and-canada/ 2023-11-29T07:03:23+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-pharmaceuticals-inc-announces-a-scientific-poster-presentation-at-the-iasp-world-congress-on-pain-on-its-lead-compound-halneuron/ 2023-11-29T07:04:02+00:00 https://cabrieladvisory.com/press-release/%e6%96%b0%e9%97%bb%e7%ae%80%e6%8a%a5%ef%bc%9awex%e5%9c%a8iasp%e4%b8%96%e7%95%8c%e7%96%bc%e7%97%9b%e5%a4%a7%e4%bc%9a%e4%b8%8a%e5%ae%a3%e5%b8%83%e4%ba%86%e5%85%b3%e4%ba%8ehalneuron/ 2023-11-29T07:04:40+00:00 https://cabrieladvisory.com/press-release/news-brief-publication-of-two-papers-using-halneuron/ 2023-11-29T07:05:16+00:00 https://cabrieladvisory.com/press-release/news-brief-wex-successfully-completes-cardiac-safety-clinic-trial-of-halneuron/ 2023-11-29T07:05:46+00:00